Advanced search
Publication Cover
Cell Cycle Volume 18, 2019 - Issue 24
Submit an article Journal homepage
852
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer

Lin Weia Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
,
Yugang Liua Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
,
Yuefeng Mab Department of Thoracic Surgery, The Second Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi, China
,
Chao Dinga Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
,
Huijun Zhanga Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
,
Zhenghui Lua Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
,
Zhenning Gua Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, China
&
Changsheng Zhua Department of Thoracic Surgery, Xi’an Chest Hospital,Xi’an, Shaanxi, ChinaCorrespondence[email protected]
 show all
Pages 3456-3471 | Received 05 Aug 2019, Accepted 08 Sep 2019, Published online: 15 Nov 2019

References

  • Group NM-aC. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383:1561–1571.
  • Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760–774.
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454.
  • David EA, Clark JM, Cooke DT, et al. The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer. J Thorac Oncol. 2017;12:1636–1645.
  • Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377:849–861.
  • Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705–716.
  • Wang JM, Deng X, Gong W, et al. Chemokines and their role in tumor growth and metastasis. J Immunol Methods. 1998;220:1–17.
  • Balkwill F. Chemokine biology in cancer. Semin Immunol. 2003;15:49–55.
  • R Setroikromo, et al. Cx chemokine receptor 7 contributes to survival of kras-mutant non-small cell lung cancer upon loss of epidermal growth factor receptor. Cancers (Basel). 2019 Mar 30;11(4). pii: E455. doi:10.3390/cancers11040455.
  • Wang L, Wang Z, Liu X, et al. High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer. Oncol Lett. 2014;7:1871–1876.
  • Sueoka H, Hirano T, Uda Y, et al. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma. Surgery. 2014;155:640–649.
  • Sharma B, Nannuru KCSaxena S, et al. CXCR2: A novel mediator of mammary tumor bone metastasis. Int J Mol Sci. 2019 Mar 12;20(5). pii: E1237. doi:10.3390/ijms20051237
  • An H, Xu L, Chang Y, et al. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma. Eur J Cancer. 2015;51:1953–1961.
  • Li YM, Liu ZYWang JC, et al. Receptor-interacting protein kinase 3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the chemokine (c-x-c motif) ligand 1-chemokine (c-x-c motif) receptor 2 axis. Hepatology. 2019 Nov;70(5):1564–1581. doi:10.1002/hep.30676.
  • Cui D, Zhao Y, Xu J. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of beta-catenin pathway. Biochimie. 2018;148:1–11.
  • Kasashima H, Yashiro M, Nakamae H, et al. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma. PLoS One. 2017;12:e0178635.
  • Cong L, Qiu ZY, Zhao Y, et al. Loss of beta-arrestin-2 and activation of CXCR2 correlate with lymph node metastasis in non-small cell lung cancer. J Cancer. 2017;8:2785–2792.
  • Hu Z, Gu X, Zhong R, et al. Tumor-infiltrating CD45RO(+) memory cells correlate with favorable prognosis in patients with lung adenocarcinoma. J Thorac Dis. 2018;10:2089–2099.
  • Burger M, Hartmann T, Burger JA, et al. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene. 2005;24:2067–2075.
  • Cheng Y, Ma XL, Wei YQ, et al. Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases. Biochim Biophys Acta Rev Cancer. 2019;1871:289–312.
  • Zhao J, Ou B, Feng H, et al. Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer. Oncotarget. 2017;8:28442–28454.
  • Raghuwanshi SK, Nasser MW, Chen X, et al. Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol. 2008;180:5699–5706.
  • Li L, Xu L, Yan J, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129.
  • Sun KH, Sun GH, Wu YC, et al. TNF-alpha augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma. J Cell Mol Med. 2016;20:2020–2028.
  • Chen MC, Baskaran R, Lee NH, et al. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Galphai-2 and Galphaq/11. J Cell Physiol. 2019;234:11822–11834.
  • Xu H, Lin F, Wang Z, et al. CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett. 2018;412:69–80.
  • Wang Y, Shen Y, Wang S, et al. The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett. 2018;415:117–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.